Pasar al contenido principal

MECANISMOS MOLECULARES IMPLICADOS EN LA DISFUNCION DE LAS SINAPSIS GLUTAMATERGICAS EN FASES TEMPRANAS DE LA ENFERMEDAD DE ALZHEIMER

SAF2014-59697-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2014
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition

  • Solé Piñol, Montserrat|||0000-0003-4240-6562
  • Esteban-Lopez, María|||0000-0002-5897-3003
  • Taltavull, Biel
  • Fábregas Ordóñez, Cristina|||0009-0001-8549-6599
  • Fadó, Rut|||0000-0002-3293-2342
  • Casals, Nuria|||0000-0002-6719-4300
  • Rodríguez Álvarez, José|||0000-0001-8582-8082
  • Miñano Molina, Alfredo Jesús|||0000-0002-7761-5682
  • Unzeta López, Mercedes|||0000-0002-7113-3383
Dysfunctions of the vascular system directly contribute to the onset and progression of Alzheimer's disease (AD). The blood-brain barrier (BBB) shows signs of malfunction at early stages of the disease. When Abeta peptide (Aβ) is deposited on brain vessels, it induces vascular degeneration by producing reactive oxygen species and promoting inflammation. These molecular processes are also related to an excessive SSAO/VAP-1 (semicarbazide-sensitive amine oxidase) enzymatic activity, observed in plasma and in cerebrovascular tissue of AD patients. We studied the contribution of vascular SSAO/VAP-1 to the BBB dysfunction in AD using in vitro BBB models. Our results show that SSAO/VAP-1 expression is associated to endothelial activation by altering the release of pro-inflammatory and pro-angiogenic angioneurins, most highly IL-6, IL-8 and VEGF. It is also related to a BBB structure alteration, with a decrease in tight-junction proteins such as zona occludens or claudin-5. Moreover, the BBB function reveals increased permeability and leukocyte adhesion in cells expressing SSAO/VAP-1, as well as an enhancement of the vascular Aβ deposition induced by mechanisms both dependent and independent of the enzymatic activity of SSAO/VAP-1. These results reveal an interesting role of vascular SSAO/VAP-1 in BBB dysfunction related to AD progression, opening a new window in the search of alternative therapeutic targets for fighting AD.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Otros (Other)

Novel regulation of the synthesis of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit gluA1 by carnitine palmitoyltransferase 1C (CPT1C) in the hippocampus

  • Fadó Andrés, Rut
  • Soto, David
  • Miñano Molina, Alfredo Jesús
  • Pozo Ariza, Macarena
  • Carrasco, Patricia
  • Yefimenko, Natalia
  • Rodríguez-Álvarez, José
  • Casals i Farré, Núria
This work was supported by Ministerio de Ciencia e Innovación (MICINN) Grants SAF2011-30520-C02-02 (to N. C.), SAF2011-30281 (to J. R.), and BFU2011-24725 (to D. S.) and Ministerio de Economía y Competitividad (MINECO) Grants SAF2014-52223-C2-2-R (to N. C.) and SAF2014-59697-R (to J. R.). This work was also supported by grants from CIBEROBN and CIBERNED (initiatives of ISCIII), the European Commission (FP7-PEOPLE2011-CIG; Grant 293498 to D. S.), the Generalitat de Catalunya (Grants SGR2009-1231, SGR2009-152, SGR2014-0984, and SGR2014-465), and Fundació La Marató de TV3 Grant 2014-36-10 (to J. R.). The authors declare that they have no conflicts of interest with the contents of this article., The regulation of AMPA-type receptor (AMPAR) abundance in the postsynaptic membrane is an important mechanism involved in learning and memory formation. Recent data suggest that one of the constituents of the AMPAR complex is carnitine palmitoyltransferase 1C (CPT1C), a brain-specific isoform located in the endoplasmic reticulum of neurons. Previous results had demonstrated that CPT1C deficiency disrupted spine maturation in hippocampal neurons and impaired spatial learning, but the role of CPT1C in AMPAR physiology had remained mostly unknown. In the present study, we show that CPT1C binds GluA1 and GluA2 and that the three proteins have the same expression profile during neuronal maturation. Moreover, in hippocampal neurons of CPT1C KO mice, AMPAR-mediated miniature excitatory postsynaptic currents and synaptic levels of AMPAR subunits GluA1 and GluA2 are significantly reduced. We show that AMPAR expression is dependent on CPT1C levels because total protein levels of GluA1 and GluA2 are decreased in CPT1C KO neurons and are increased in CPT1C-overexpressing neurons, whereas other synaptic proteins remain unaltered. Notably, mRNA levels of AMPARs remained unchanged in those cultures, indicating that CPT1C is post-transcriptionally involved. We demonstrate that CPT1C is directly involved in the de novo synthesis of GluA1 and not in protein degradation. Moreover, in CPT1C KO cultured neurons, GluA1 synthesis after chemical long term depression was clearly diminished, and brain-derived neurotrophic factor treatment was unable to phosphorylate the mammalian target of rapamycin (mTOR) and stimulate GluA1 protein synthesis. These data newly identify CPT1C as a regulator of AMPAR translation efficiency and therefore also synaptic function in the hippocampus., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Proteasomal-mediated degradation of AKAP150 accompanies AMPAR endocytosis during cLTD

  • Cheng, Wenwen
  • Siedlecki-Wullich, Dolores
  • Català-Solsona, Judit
  • Fábregas, Cristina
  • Fadó Andrés, Rut
  • Casals i Farré, Núria
  • Solé, Montse
  • Unzeta, Mercedes
  • Saura, Carlos A.
  • Rodríguez-Álvarez, José
  • Miñano Molina, Alfredo Jesús
The number and function of synaptic AMPA receptors (AMPARs) tightly regulates excitatory synaptic transmission. Current evidence suggests that AMPARs are inserted into the postsynaptic membrane during long-term potentiation (LTP) and are removed from the membrane during long-term depression (LTD). Dephosphorylation of GluA1 at Ser-845 and enhanced endocytosis are critical events in the modulation of LTD. Moreover, changes in scaffold proteins from the postsynaptic density (PSD) could be also related to AMPAR regulation in LTD. In the present study we analyzed the effect of chemical LTD (cLTD) on A-kinase anchoring protein (AKAP)150 and AMPARs levels in mouse-cultured neurons. We show that cLTD induces AKAP150 protein degradation via proteasome, coinciding with GluA1 dephosphorylation at Ser-845 and endocytosis of GluA1-containing AMPARs. Pharmacological inhibition of proteasome activity, but not phosphatase calcineurin (CaN), reverted cLTD-induced AKAP150 protein degradation. Importantly, AKAP150 silencing induced dephosphorylation of GluA1 Ser-845 and GluA1-AMPARs endocytosis while AKAP150 overexpression blocked cLTD-mediated GluA1-AMPARs endocytosis. Our results provide direct evidence that cLTD-induced AKAP150 degradation by the proteasome contributes to synaptic AMPARs endocytosis., info:eu-repo/semantics/acceptedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease

  • Siedlecki-Wullich, Dolores|||0000-0002-9099-9406
  • Català-Solsona, Judit|||0000-0002-2927-9135
  • Fábregas Ordóñez, Cristina
  • Hernández, Isabel|||0000-0001-8119-393X
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Lleó, Alberto|||0000-0002-2568-5478
  • Boada, Mercè|||0000-0003-2617-3009
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Rodríguez Álvarez, José|||0000-0001-8582-8082
  • Miñano Molina, Alfredo Jesús|||0000-0002-7761-5682
Several evidences suggest that failure of synaptic function occurs at preclinical stages of Alzheimer's disease (AD) preceding neuronal loss and the classical AD pathological hallmarks. Nowadays, there is an urgent need to identify reliable biomarkers that could be obtained with non-invasive methods to improve AD diagnosis at early stages. Here, we have examined plasma levels of a group of miRNAs related to synaptic proteins in a cohort composed of cognitive healthy controls (HC), mild cognitive impairment (MCI) and AD subjects. Plasma and brain levels of miRNAs were analysed in two different cohorts including 38 HC, 26 MCI, 56 AD dementia patients and 27 frontotemporal dementia (FTD) patients. D'Agostino and Pearson and Shapiro-Wilk tests were used to evaluate data normality. miRNA levels between groups were compared using a two-sided nonparametric Mann-Whitney test and sensitivity and specificity was determined by receiver operating characteristic curve analysis. Significant upregulation of miR-92a-3p, miR-181c-5p and miR-210-3p was found in the plasma of both MCI and AD subjects. MCI patients that progress to AD showed higher plasma levels of these miRNAs. By contrast, no changes in miR-92a-3p, miR-181c-5p or miR-210-3p levels were observed in plasma obtained from a cohort of FTD. Our study shows that plasma miR-92a-3p, miR-181c-5p and miR-210-3p constitute a specific molecular signature potentially useful as a potential biomarker for AD. The online version of this article (10.1186/s13195-019-0501-4) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Proteasomal-Mediated Degradation of AKAP150 Accompanies AMPAR Endocytosis during cLTD

  • Cheng, Wenwen|||0000-0002-5462-8245
  • Siedlecki-Wullich, Dolores|||0000-0002-9099-9406
  • Català-Solsona, Judit|||0000-0002-2927-9135
  • Fábregas Ordóñez, Cristina
  • Fadó, Rut|||0000-0002-3293-2342
  • Casals, Nuria|||0000-0002-6719-4300
  • Solé Piñol, Montserrat|||0000-0003-4240-6562
  • Unzeta López, Mercedes|||0000-0002-7113-3383
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Rodríguez Álvarez, José|||0000-0001-8582-8082
  • Miñano Molina, Alfredo Jesús|||0000-0002-7761-5682
The number and function of synaptic AMPA receptors (AMPARs) tightly regulates excitatory synaptic transmission. Current evidence suggests that AMPARs are inserted into the postsynaptic membrane during long-term potentiation (LTP) and are removed from the membrane during long-term depression (LTD). Dephosphorylation of GluA1 at Ser-845 and enhanced endocytosis are critical events in the modulation of LTD. Moreover, changes in scaffold proteins from the postsynaptic density (PSD) could be also related to AMPAR regulation in LTD. In the present study we analyzed the effect of chemical LTD (cLTD) on A-kinase anchoring protein (AKAP)150 and AMPARs levels in mouse-cultured neurons. We show that cLTD induces AKAP150 protein degradation via proteasome, coinciding with GluA1 dephosphorylation at Ser-845 and endocytosis of GluA1-containing AMPARs. Pharmacological inhibition of proteasome activity, but not phosphatase calcineurin (CaN), reverted cLTD-induced AKAP150 protein degradation. Importantly, AKAP150 silencing induced dephosphorylation of GluA1 Ser-845 and GluA1-AMPARs endocytosis while AKAP150 overexpression blocked cLTD-mediated GluA1-AMPARs endocytosis. Our results provide direct evidence that cLTD-induced AKAP150 degradation by the proteasome contributes to synaptic AMPARs endocytosis.